GoHealth, Inc. (GOCO)
NASDAQFinancialsInsurance - BrokersSnapshot 2026-11-05
$0.30+5.14%
Close 2026-06-15 · 1-day change
NASDAQFinancialsInsurance - BrokersSnapshot 2026-11-05
Research Workspace
Put GOCO beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Successful progress in Chapter 11 restructuring: Direct metric needs a verified mapping.
View ThesisRevenue is contracting — down about 82% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery, margins, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 99% in its worst 12-month stretch.
View RiskGOCO trades below its sector peers. The company is unprofitable. Recent performance is weak. Management is unsteady. The market cycle is in mania. Our model puts the next-quarter miss near 54%. The primary pillar is under pressure. The thesis comparison is not yet verified. Our standing thesis is on watch. This read is provisional.
Trailing returns as of 2026-06-15. GOCO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 5 analysts currently covering GOCO (as of Jun 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare GOCO with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| GOCO Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Insurance Brokers — fair value, gap to price, and forward P/E.
Compare the value case
Put GOCO next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Chapter 11 restructuring process
Bankruptcy filing undermines restructuring efforts.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-06-15. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Chapter 11 restructuring process
Chapter 11 filing disrupts management's restructuring plan.